Clearance Summary
NASAL SPLINT received FDA 510(k) clearance under submission number K945555, sponsored by Ultracell Medical Technologies, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Ear, Nose, Throat review panel. The statutory decision date of record is 1995-01-19.
- Submission: K945555
- Applicant / Sponsor: Ultracell Medical Technologies, Inc.
- Clearance pathway: Traditional
- Review panel: Ear, Nose, Throat
- Device class: Class I
- Regulation citation: 21 CFR 874.4780
- Decision date: 1995-01-19
Classification & Regulation
This clearance is catalogued under FDA product code LYA and 21 CFR 874.4780, within the Ear, Nose, Throat review panel as a Class I device.